Stock Rating Upgrade
In recent days the Value Trend Rating for Corcept Therapeutics Inc (NASDAQ: CORT) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 7/29/24, Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a large increase of 2.6%, closing at $36.53. Moreover, trading volume in this advance was unusually high at 155% of normal. The stock has risen 7.8% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CORT is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Corcept Therapeutics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Corcept Therapeutics has a very low Appreciation Score of 12 but a good Power Rating of 78, triggering the Low Neutral Value Trend Rating.
Be the first to comment